{"id":"https://openalex.org/W3043818052","doi":"https://doi.org/10.1158/1078-0432.ccr-20-1170","title":"Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study","display_name":"Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study","alternate_titles":[],"publication_year":2020,"publication_date":"2020-07-15","ids":{"openalex":"https://openalex.org/W3043818052","doi":"https://doi.org/10.1158/1078-0432.ccr-20-1170","mag":"3043818052","pmid":"https://pubmed.ncbi.nlm.nih.gov/32669371"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-20-1170","doi":"https://doi.org/10.1158/1078-0432.ccr-20-1170","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-1170","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3043818052"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://archive-ouverte.unige.ch/unige:155815","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072284989","display_name":"Kevin Joseph Harrington","orcid":"https://orcid.org/0000-0002-6014-348X","observed_orcids":["https://orcid.org/0000-0002-6014-348X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin J. Harrington","raw_affiliation_strings":["1The Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071537151","display_name":"Anthony H. Kong","orcid":"https://orcid.org/0000-0002-3989-3948","observed_orcids":["https://orcid.org/0000-0002-3989-3948"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anthony Kong","raw_affiliation_strings":["2Institute of Cancer and Genomic Science, University of Birmingham, Birmingham, United Kingdom","3Comprehensive Cancer Centre, King's College London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Institute of Cancer and Genomic Science, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"3Comprehensive Cancer Centre, King's College London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020235177","display_name":"Nicolas Mach","orcid":"https://orcid.org/0000-0001-8944-1088","observed_orcids":["https://orcid.org/0000-0001-8944-1088"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Nicolas Mach","raw_affiliation_strings":["4Department of Oncology, University Hospital of Geneva, Geneva, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-8944-1088","affiliations":[{"raw_affiliation_string":"4Department of Oncology, University Hospital of Geneva, Geneva, Switzerland","institution_ids":["https://openalex.org/I4210106256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086165685","display_name":"Jason Alan Chesney","orcid":"https://orcid.org/0000-0003-0217-8278","observed_orcids":["https://orcid.org/0000-0003-0217-8278"]},"institutions":[{"id":"https://openalex.org/I142740786","display_name":"University of Louisville","ror":"https://ror.org/01ckdn478","country_code":"US","type":"education","lineage":["https://openalex.org/I142740786"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason A. Chesney","raw_affiliation_strings":["5James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky","institution_ids":["https://openalex.org/I142740786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045972021","display_name":"Beatriz Castelo Fern\u00e1ndez","orcid":"https://orcid.org/0000-0002-5824-9808","observed_orcids":["https://orcid.org/0000-0002-5824-9808"]},"institutions":[{"id":"https://openalex.org/I2800562746","display_name":"Hospital Universitario La Paz","ror":"https://ror.org/01s1q0w69","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Beatriz Castelo Fernandez","raw_affiliation_strings":["6Medical Oncology Department, University Hospital La Paz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Medical Oncology Department, University Hospital La Paz, Madrid, Spain","institution_ids":["https://openalex.org/I2800562746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060469120","display_name":"Danny Rischin","orcid":"https://orcid.org/0000-0002-3368-0386","observed_orcids":["https://orcid.org/0000-0002-3368-0386"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Danny Rischin","raw_affiliation_strings":["7Peter MacCallum Cancer Centre, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Peter MacCallum Cancer Centre, Melbourne, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001334189","display_name":"Ezra E.W. Cohen","orcid":"https://orcid.org/0000-0002-9872-6242","observed_orcids":["https://orcid.org/0000-0002-9872-6242"]},"institutions":[{"id":"https://openalex.org/I2800935791","display_name":"UC San Diego Health System","ror":"https://ror.org/01kbfgm16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezra E.W. Cohen","raw_affiliation_strings":["8Moores Cancer Center UC San Diego Health, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Moores Cancer Center UC San Diego Health, La Jolla, California","institution_ids":["https://openalex.org/I2800935791","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044534049","display_name":"Hoi-Shen Radcliffe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hoi-Shen Radcliffe","raw_affiliation_strings":["9Amgen Limited, Uxbridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Amgen Limited, Uxbridge, United Kingdom","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059172426","display_name":"Burak G\u00fcm\u00fc\u015f\u00e7\u00fc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Burak Gumuscu","raw_affiliation_strings":["10Merck & Co., Inc., Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Merck & Co., Inc., Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112748795","display_name":"Jonathan D. Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Cheng","raw_affiliation_strings":["10Merck & Co., Inc., Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Merck & Co., Inc., Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067343702","display_name":"WENDY J. SNYDER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Snyder","raw_affiliation_strings":["11Amgen, Inc., Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Amgen, Inc., Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000204204","display_name":"Lillian L. Siu","orcid":"https://orcid.org/0000-0002-3500-0540","observed_orcids":["https://orcid.org/0000-0002-3500-0540"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lillian L. Siu","raw_affiliation_strings":["12Princess Margaret Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":"https://orcid.org/0000-0002-3500-0540","affiliations":[{"raw_affiliation_string":"12Princess Margaret Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.3711,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.99378347,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"26","issue":"19","first_page":"5153","last_page":"5161"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talimogene-laherparepvec","display_name":"talimogene laherparepvec","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma","display_name":"recurrent or metastatic head and neck squamous cell carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/oncolytic-immunotherapy","display_name":"oncolytic immunotherapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7379999756813049},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8809999823570251},{"id":"https://openalex.org/keywords/arterial-hemorrhage","display_name":"arterial hemorrhage","score":0.8270000219345093},{"id":"https://openalex.org/keywords/platinum-refractory-disease","display_name":"platinum-refractory disease","score":0.7730000019073486},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5180000066757202},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8087621927261353},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8037691116333008},{"id":"https://openalex.org/C3018411727","wikidata":"https://www.wikidata.org/wiki/Q3867488","display_name":"Head and neck","level":2,"score":0.6626235842704773},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.5230867862701416},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49676352739334106},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.44922131299972534},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.4449385404586792},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39397871494293213},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.36832427978515625},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.34164148569107056},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32397615909576416},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18470990657806396},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.13618123531341553},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1266193985939026}],"mesh":[{"descriptor_ui":"D000077195","descriptor_name":"Squamous Cell Carcinoma of Head and Neck","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000077195","descriptor_name":"Squamous Cell Carcinoma of Head and Neck","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000077195","descriptor_name":"Squamous Cell Carcinoma of Head and Neck","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D018259","descriptor_name":"Herpesvirus 1, Human","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050130","descriptor_name":"Oncolytic Virotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-20-1170","doi":"https://doi.org/10.1158/1078-0432.ccr-20-1170","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-1170","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:32669371","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32669371","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:unige.ch:aou:unige:155815","doi":null,"is_oa":false,"landing_page_url":"https://archive-ouverte.unige.ch/unige:155815","pdf_url":null,"source":{"id":"https://openalex.org/S4306402259","display_name":"Archive ouverte UNIGE (University of Geneva)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114457229","host_organization_name":"University of Geneva","host_organization_lineage":["https://openalex.org/I114457229"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISSN: 1078-0432","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:unige.ch:unige:155815","doi":null,"is_oa":true,"landing_page_url":"https://archive-ouverte.unige.ch/unige:155815","pdf_url":null,"source":{"id":"https://openalex.org/S4306402259","display_name":"Archive ouverte UNIGE (University of Geneva)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114457229","host_organization_name":"University of Geneva","host_organization_lineage":["https://openalex.org/I114457229"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 1078-0432","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:unige.ch:unige:155815","doi":null,"is_oa":true,"landing_page_url":"https://archive-ouverte.unige.ch/unige:155815","pdf_url":null,"source":{"id":"https://openalex.org/S4306402259","display_name":"Archive ouverte UNIGE (University of Geneva)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114457229","host_organization_name":"University of Geneva","host_organization_lineage":["https://openalex.org/I114457229"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 1078-0432","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1870944776","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0515-10101","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G5156121855","display_name":null,"funder_award_id":"M48-F1","funder_id":"https://openalex.org/F4320320320","funder_display_name":"Rosetrees Trust"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320315071","display_name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320320","display_name":"Rosetrees Trust","ror":"https://ror.org/04e3zg361"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W244067726","https://openalex.org/W1982488143","https://openalex.org/W2099648846","https://openalex.org/W2108216382","https://openalex.org/W2109274792","https://openalex.org/W2110664940","https://openalex.org/W2112845420","https://openalex.org/W2118982164","https://openalex.org/W2122639773","https://openalex.org/W2153778867","https://openalex.org/W2159631730","https://openalex.org/W2288651793","https://openalex.org/W2320299038","https://openalex.org/W2347070489","https://openalex.org/W2401455386","https://openalex.org/W2427476638","https://openalex.org/W2473956396","https://openalex.org/W2529484692","https://openalex.org/W2602907503","https://openalex.org/W2750781282","https://openalex.org/W2763265527","https://openalex.org/W2811088815","https://openalex.org/W2889646458","https://openalex.org/W2903493423","https://openalex.org/W2986633517"],"related_works":["https://openalex.org/W2889801607","https://openalex.org/W3169399702","https://openalex.org/W2762423463","https://openalex.org/W2778712987","https://openalex.org/W4400875117","https://openalex.org/W4313568906","https://openalex.org/W4241565242","https://openalex.org/W7160645156","https://openalex.org/W4399370041","https://openalex.org/W4406115443"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,113,203,217],"prognosis":[2],"for":[3,36,177],"patients":[4,24,105,142,174],"with":[5,41,66,219,226],"recurrent":[6],"or":[7],"metastatic":[8],"head":[9],"and":[10,19,94,101,139,150,185,195,207],"neck":[11],"squamous":[12],"cell":[13],"carcinoma":[14],"(R/M":[15],"HNSCC)":[16],"is":[17],"poor,":[18],"only":[20],"a":[21,57,210],"minority":[22],"of":[23,83,130,205,236],"benefit":[25],"from":[26],"checkpoint":[27],"immunotherapy.":[28],"Talimogene":[29],"laherparepvec":[30],"(T-VEC),":[31],"an":[32],"oncolytic":[33],"immunotherapy":[34],"approved":[35],"advanced":[37],"melanoma,":[38],"in":[39,69,168,214,229],"combination":[40,204,221],"pembrolizumab":[42,68,208,227],"may":[43],"yield":[44],"enhanced":[45],"antitumor":[46],"activity":[47],"over":[48],"either":[49],"agent":[50],"alone.":[51],"PATIENTS":[52],"AND":[53],"METHODS:":[54],"This":[55],"was":[56,81,117,123,135,166,222,239],"phase":[58,77,110],"Ib/III,":[59],"multicenter":[60],"trial":[61],"testing":[62],"intratumoral":[63],"T-VEC":[64,149,206],"combined":[65],"intravenous":[67],"R/M":[70,215],"HNSCC":[71,231],"refractory":[72],"to":[73,148,180,224],"platinum-based":[74],"chemotherapy.":[75],"For":[76],"Ib,":[78],"primary":[79],"endpoint":[80],"incidence":[82],"dose-limiting":[84],"toxicity":[85],"(DLT).":[86],"Key":[87],"secondary":[88],"endpoints":[89],"included":[90],"objective":[91],"response":[92,165,178],"rate":[93],"progression-free":[95],"survival":[96],"per":[97],"irRECIST,":[98],"overall":[99],"survival,":[100],"safety.":[102],"RESULTS:":[103],"Thirty-six":[104],"were":[106,157,175,187],"enrolled":[107],"into":[108],"the":[109,154,220],"Ib":[111],"study.":[112],"data":[114],"cut-off":[115],"date":[116],"August":[118],"28,":[119],"2018.":[120],"Median":[121,183],"follow-up":[122],"5.8":[124,196],"months":[125,189,197],"(range,":[126],"0.3-24.2).":[127],"One":[128],"DLT":[129],"T-VEC-related":[131],"fatal":[132,160],"arterial":[133],"hemorrhage":[134],"reported.":[136],"Twenty":[137],"(55.6%)":[138],"21":[140],"(58.3%)":[141],"experienced":[143],"adverse":[144],"events":[145],"(AE)":[146],"related":[147],"pembrolizumab,":[151],"respectively.":[152,201],"Besides":[153],"DLT,":[155],"there":[156],"no":[158],"treatment-related":[159],"AEs.":[161],"A":[162],"confirmed":[163],"partial":[164],"observed":[167],"5":[169],"(13.9%)":[170],"patients.":[171],"Ten":[172],"(27.8%)":[173],"unevaluable":[176],"due":[179],"early":[181],"death.":[182],"PFS":[184],"OS":[186],"3.0":[188],"[95%":[190],"confidence":[191],"interval":[192],"(Cl),":[193],"2.0-5.8]":[194],"(95%":[198],"Cl,":[199],"2.9-11.4),":[200],"CONCLUSIONS:":[202],"demonstrated":[209],"tolerable":[211],"safety":[212],"profile":[213],"HNSCC.":[216],"efficacy":[218],"similar":[223],"that":[225],"monotherapy":[228],"historical":[230],"studies.":[232],"Phase":[233],"III":[234],"part":[235],"this":[237],"study":[238],"not":[240],"further":[241],"pursued":[242],"(ClinicalTrials.gov":[243],"Identifier:":[244],"NCT02626000).":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3043818052","counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":26},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":23},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-07-23T00:00:00"}
